EchoSolv AS vs EchoGo Pro
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary objective is to accurately and efficiently identify patients at high risk for severe aortic stenosis using AI-powered clinical decision support. This tool is ideal for clinics seeking a measurement-based AI that provides consistent probability and guideline checks, helping prioritize studies for review and integrating seamlessly with PACS without requiring EMR integration.
View EchoSolv AS →Choose EchoGo Pro if…
Choose EchoGo Pro if you need to automate and enhance the diagnostic accuracy of coronary artery disease through stress echocardiography analysis. This cloud-based, vendor-neutral AI solution is best suited for institutions looking for near-instant, comprehensive reports and seamless integration with existing clinical workflows (DICOM, HL7) to improve efficiency and scalability in CAD diagnosis.
View EchoGo Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | EchoGo Pro |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Cloud-based | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoGo ProEchoGo Pro offers a 'zero-click, off-the-cart usage approach' and requires no software installation or extensive training, streamlining the user experience significantly [cite: 4, JSON]. While EchoSolv AS is fast and integrates into existing workflows, EchoGo Pro's minimal interaction design provides a slight edge in reducing clinician burden. EchoGo Pro also generates reports within minutes, while EchoSolv AS offers ultra-fast risk detection under 3 seconds [cite: 2, 11, 14, 40, JSON].
Clinical Value
EchoSolv ASBoth tools are FDA-cleared and clinically validated in their respective domains. EchoSolv AS has demonstrated 'near-perfect accuracy' in detecting severe aortic stenosis, with an AUC of 0.986 and outperforming traditional clinical interpretation in validation studies at leading institutions. EchoGo Pro also shows strong diagnostic performance for coronary artery disease, improving sensitivity by 10% compared to clinician judgment alone.
Pricing & Value
EchoGo ProEchoGo Pro provides more transparent information regarding its pricing models (pay-per-use or subscription) and explicitly mentions being one of the first AI echocardiography solutions to achieve Category III CPT reimbursement in the U.S.. It also lists specific reimbursement codes and average Medicare amounts for related EchoGo products, indicating a clearer path to financial viability for providers [cite: 27, 39, JSON]. EchoSolv AS mentions a subscription model and a pathway to reimbursement codes, but with fewer specific details for the product itself.
Enterprise Readiness
EchoGo ProBoth tools are cloud-based, FDA-cleared, HIPAA compliant, and integrate with PACS. However, EchoGo Pro explicitly details seamless integration with standard clinical workflows using DICOM and HL7, and is a 'vendor-neutral system' [JSON]. It also holds ISO13485 certification, demonstrating a comprehensive approach to quality management and enterprise deployment. EchoSolv AS offers SOC 2 Type II and HIPAA audit reports, but EchoGo Pro's broader integration specifics and certifications give it a slight advantage.
Innovation
EchoGo ProEchoGo Pro has been recognized with the Frost & Sullivan 2020 Global New Product Innovation Award and is described as a 'world-first' AI-powered tool for predicting coronary artery disease risk from stress echocardiography. While EchoSolv AS employs an innovative measurement-based AI and a mixture density network approach, EchoGo Pro's external accolades and specific 'world-first' claims for its application area highlight its pioneering status.
Support & Docs
EchoSolv ASEchoSolv AS explicitly offers 'Echo IQ API Documentation' and a 'Clinician user manual u2013 EchoSolv AS' for its product, indicating readily available and detailed technical and user-facing resources. While EchoGo Pro mentions 'Customer Support' and 'dedicated support and customer success teams,' the explicit availability of comprehensive documentation for EchoSolv AS suggests a more robust offering in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | EchoGo Pro |
|---|---|---|
| Name | EchoSolv AS | EchoGo Pro |
| Company | Echo IQ | Ultromics |
| Primary Clinical Focus | Identifies patients at risk for severe aortic stenosis (sAS) | Automates stress echocardiography analysis to improve diagnosis of coronary artery disease (CAD) |
| Analysis Method | Measurement-based AI (analyzes numerical measurements, not images) | AI-powered automated echocardiogram analysis |
| Integration | Designed to fit existing workflows (no EMR integration required, integrates with PACS) | Seamless integration with existing clinical workflows (DICOM, HL7), Vendor-neutral system, compatible with any PACS |
| Analysis Speed | Ultra-fast risk detection (under 3 seconds) | Provides near-instant, comprehensive reports |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and EchoGo Pro.